Apotex vs. Large Pharma: The Battle Continues
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 76 (Table of Contents)
Published: 6 Oct-2006
DOI: 10.3833/pdr.v2006.i76.448 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
Apotex launched generic version of Plavix® an antiplatelet agent for treating thrombotic conditions which is already marketed by Bristol-Myers Squibb and Sanofi-Aventis after the proposed settlement between the parties were rejected...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS